f Emerging Frontiers in Disease Modelling: Data to Drug Discovery in Bioinformatics in Precision Medicine and Health Science

References

1. Chowdhury A. Garai S. Mukherjee D. In silico prediction of human intestinal permeability (Caco-2) using QSPR modelling for efficient drug discovery. Curr. Drug Discov. Technol. 2026 23 2 3 16 10.2174/0115701638360381250604034810 40530731
   [Google Scholar]
2. Biswas I. Biswas T. Mitra D. Bioactive flavonoids and phenolic acids of Petroselinum crispum as a potential inhibitor of α-amylase: An in silico evaluation. Curr. Drug Discov. Technol. 2026 23 2 17 29 10.2174/0115701638361734250414033830 40325814
   [Google Scholar]
3. Chouhan M. Kumar M. Mishra R. Computational investigation of phytochemicals targeting isocitrate lyase to inhibit Mycobacterium tuberculosis. Curr. Drug Discov. Technol. 2026 23 2 30 42 10.2174/0115701638364461250603050239 40530732
   [Google Scholar]
4. Gupta J. Gupta A. Bhattacharya D. Nag M. Lahiri D. Mitra D. Bioactive compounds as a potential inhibitor of biofilm production: An in silico study to identify natural hindrance resources. Curr. Drug Discov. Technol. 2026 23 2 43 62 10.2174/0115701638367145250418033053 40325815
   [Google Scholar]
5. Bhattacharya D. Gupta J. Gupta A. Nag M. Lahiri D. Mitra D. In silico analysis to search for an alternative inhibitor of biofilm production by Helicobacter pylori. Curr. Drug Discov. Technol. 2026 23 2 63 70 10.2174/0115701638369494250723071458 40765099
   [Google Scholar]